ArticleHeliyon2024

Prognostic model based on M2 macrophage-related signatures for predicting outcomes, enhancing risk stratification, and providing therapeutic insights in diffuse large B-cell lymphoma.

Baoping Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.